POSTERS ASCO 2024

Tumores del sistema nervioso central

Azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II CAN-201 NDG trial design.

Azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II CAN-201 NDG trial design.

Abstract: TPS2096 Poster Bd #: 391b

Poster

Descargar

Autor
Estela Pineda Losada, MD, PhD

Medical Oncologist at Hospital Clínic Barcelona

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON